Welcure Drugs & Pharmaceuticals Shareholding Pattern

As of Dec 2025, Welcure Drugs & Pharmaceuticals (WELCURE) promoter holding 0.00%, FII 0.00%, DII 0.00%, public 94.41%, total shareholders 87,288. For live price, key ratios and the full company profile, see WELCURE stock overview.

Promoter Holding 0.00%
FII Holding 0.00%
DII Holding 0.00%
Public Holding 94.41%
Total Shareholders 87,288
As of Dec 2025

WELCURE Recent Shareholding Changes — Promoter, FII & DII

Welcure Drugs & Pharmaceuticals promoter, FII and DII holding change from Sept 2025 to Dec 2025. Compare with Welcure Drugs & Pharmaceutical value estimation to assess whether the stock is under or overvalued.

Promoter Holding Change
Sept 2025 to Dec 2025
No Change
FII Holding Change
Sept 2025 to Dec 2025
No Change
DII Holding Change
Sept 2025 to Dec 2025
No Change
Public Holding Change
Sept 2025 to Dec 2025
+2.58%

Welcure Drugs & Pharmaceuticals Quarterly Shareholding Trend — Promoter, FII, DII & Public

WELCURE promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. Review WELCURE P/E comparison to evaluate earnings-based valuation against sector peers.

Promoter
FII
DII
Public
Government

WELCURE Shareholding Pattern Data — Quarterly History

Welcure Drugs & Pharmaceuticals quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 0.00% 0.00% 0.00% 0.00% 94.41% 5.59% 100.00% 87,288
Sept 2025 0.00% 0.00% 0.00% 0.00% 91.83% 8.17% 100.00% 76,954
Jun 2025 0.00% 0.00% 0.00% 0.00% 98.74% 1.26% 100.00% 37,298
Mar 2025 0.00% 0.00% 0.00% 0.00% 98.99% 1.01% 100.00% 32,366
Dec 2024 0.00% 0.00% 0.00% 0.00% 98.79% 1.21% 100.00% 30,605
Sept 2024 0.00% 0.00% 0.00% 0.00% 93.55% 6.45% 100.00% 30,218
Jun 2024 0.00% 0.00% 0.00% 0.00% 93.14% 6.86% 100.00% 31,045
Mar 2024 0.00% 0.00% 0.00% 0.00% 93.69% 6.31% 100.00% 31,530
Dec 2023 0.00% 0.00% 0.00% 0.00% 93.87% 6.13% 100.00% 29,957
Sept 2023 0.00% 0.00% 0.00% 0.00% 94.28% 5.72% 100.00% 29,593
Jun 2023 0.00% 0.00% 0.00% 0.00% 93.68% 6.32% 100.00% 29,251
Mar 2023 0.00% 0.00% 0.01% 0.00% 93.64% 6.34% 99.99% 29,013
Dec 2022 0.00% 0.00% 0.01% 0.00% 93.73% 6.26% 100.00% 29,075
Sept 2022 0.00% 0.00% 0.01% 0.00% 88.34% 11.65% 100.00% 24,699
Jun 2022 14.12% 0.00% 0.01% 0.00% 76.91% 8.95% 99.99% 20,463
Mar 2022 14.12% 0.00% 0.01% 0.00% 76.04% 9.82% 99.99% 18,951
Dec 2021 14.12% 0.00% 0.01% 0.00% 76.27% 9.59% 99.99% 18,909
Sept 2021 14.12% 0.00% 0.01% 0.00% 75.07% 10.80% 100.00% 17,380
Jun 2021 14.12% 0.00% 0.01% 0.00% 73.81% 12.05% 99.99% 16,524
Mar 2021 14.12% 0.00% 0.01% 0.00% 73.82% 12.04% 99.99% 16,542
Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 0.00% 0.00% 0.00% 0.00% 94.41% 5.59% 100.00% 87,288
Sept 2025 0.00% 0.00% 0.00% 0.00% 91.83% 8.17% 100.00% 76,954
Jun 2025 0.00% 0.00% 0.00% 0.00% 98.74% 1.26% 100.00% 37,298
Mar 2025 0.00% 0.00% 0.00% 0.00% 98.99% 1.01% 100.00% 32,366
Dec 2024 0.00% 0.00% 0.00% 0.00% 98.79% 1.21% 100.00% 30,605
Sept 2024 0.00% 0.00% 0.00% 0.00% 93.55% 6.45% 100.00% 30,218
Jun 2024 0.00% 0.00% 0.00% 0.00% 93.14% 6.86% 100.00% 31,045
Mar 2024 0.00% 0.00% 0.00% 0.00% 93.69% 6.31% 100.00% 31,530
Dec 2023 0.00% 0.00% 0.00% 0.00% 93.87% 6.13% 100.00% 29,957
Sept 2023 0.00% 0.00% 0.00% 0.00% 94.28% 5.72% 100.00% 29,593
Jun 2023 0.00% 0.00% 0.00% 0.00% 93.68% 6.32% 100.00% 29,251
Mar 2023 0.00% 0.00% 0.01% 0.00% 93.64% 6.34% 99.99% 29,013
Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 0.00% 0.00% 0.00% 0.00% 94.41% 5.59% 100.00% 87,288
Dec 2024 0.00% 0.00% 0.00% 0.00% 98.79% 1.21% 100.00% 30,605
Dec 2023 0.00% 0.00% 0.00% 0.00% 93.87% 6.13% 100.00% 29,957
Dec 2022 0.00% 0.00% 0.01% 0.00% 93.73% 6.26% 100.00% 29,075
Dec 2021 14.12% 0.00% 0.01% 0.00% 76.27% 9.59% 99.99% 18,909